At the end of last week, an FDA advisory panel voted down BrainsGate’s neurostimulation device for treating stroke. BrainsGate designed its technology as a five-minute procedure. A neurostimulator implant is injected into an existing canal to stimulate a nerve center and augment collateral blood flow, improving stroke patients’ outcomes within a 24-hour window. The platform […]
BrainsGate
BrainsGate raises $14M
Ischemic stroke treatment developer BrainsGate announced today that it secured a $14 million investment to fund future regulatory efforts. Caesarea, Israel-based BrainsGate’s funding round included contributions from new investor BNP Joint Capital Fund, which led the round along with investment and consulting firm SPERO. Elron, Medtronic, Agate, Pitango and Cipio also participated in the round. […]